NRx and Israel Developing Covid-19 Vaccine to Attack Variants

55

Aug.30 — NRx Pharmaceuticals CEO Dr. Jonathan Javitt says they are working with Israel on a Covid-19 vaccine that targets Covid variants. He says vaccines from last year are becoming less effective. He’s on “Bloomberg Markets.”